Immunological and parasitological parameters after treatment with dexamethasone in murine Schistosoma mansoni

AUTOR(ES)

Aly, Ibrahim RB, Hendawy, Mohamed A, Ali, Eman, Hassan, Eman, Nosseir, Mona MF

FONTE

Memórias do Instituto Oswaldo Cruz

DATA DE PUBLICAÇÃO

2010-09

RESUMO

This work aimed to evaluate the effect of diphenyl dimethyl bicarboxylate (DDB) and dexamethasone alone and in combination with praziquantel on various parasitological, immunological and pathological parameters reflecting disease severity and morbidity in murine schistosomiasis. DDB and dexamethasone had no effect on worm burden but altered tissue egg distribution. This indicates that, under the schedule used, neither drug interfered with the development of adult worms or oviposition, but both can modulate liver pathology. Dexamethasone resulted in a greater reduction in granuloma size than did DDB. Dexamethasone-treated mice also showed lower levels of serum gamma interferon (IFN-γ), interleukin-12 (IL-12) and IL-4, together with higher IL-10 levels, than infected untreated control animals. These data suggest that dexamethasone is a convenient and promising coadjuvant agent that results in decreased morbidity in murine schistosomiasis.

Documentos Relacionados

• Parasitological characteristics of Schistosoma mansoni infection in swiss mice with underlying malnutrition
• Parasitological and histological aspects of Holochilus sciureus naturally infected by Schistosoma mansoni
• Dexamethasone, a Drug for Attenuation of Schistosoma mansoni Infection Morbidity
• The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
• Changes in IgE- and Antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel